Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation

Cornea

Volumn 32, Issue 5, 2013, Pages

  Ivanir, Yair ^a   Shimoni, Avichai ^a   Ezra Nimni, Orit ^a   Barequet, Irina S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

dry eye; graft versus host

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL OBSERVATION; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRY EYE; EYE EXAMINATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCHIRMER TEST; SCORING SYSTEM; TREATMENT DURATION; VISUAL ACUITY;

ADULT; AGED; CORNEA; CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; FEMALE; FLUOROPHOTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TEARS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VISUAL ACUITY; YOUNG ADULT;

EID: 84876282840     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318276bc56     Document Type: Article

References (34)

1. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I: diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2005;11:945-956. (Pubitemid 41754712)
2. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009;373:1550-1561.
3. Couriel D, Caldera H, Champlin R, et al. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101:1936-1946. (Pubitemid 39425368)
4. Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15:503-507. (Pubitemid 39564472)
5. Calissendorff B, el Azazi M, Lönnqvist B. Dry eye syndrome in longterm follow-up of bone marrow transplanted patients. Bone Marrow Transpl. 1989;4:675-678. (Pubitemid 20020754)
6. Mencucci R, Rossi Ferrini C, Bosi A, et al. Ophthalmological aspects in allogenic bone marrow transplantation: Sjögren-like syndrome in graftversus-host disease. Eur J Ophthalmol. 1997;7:13-18. (Pubitemid 27140435)
7. Jack MK, Hicks JD. Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol. 1981;13:709-711. (Pubitemid 11117159)
8. Hassan AS, Clouthier SG, Ferrara JL, et al. Lacrimal gland involvement in graft-versus-host disease: a murine model. Invest Ophthalmol Vis Sci. 2005;46:2692-2697. (Pubitemid 43086688)
9. Ogawa Y, Yamazaki K, Kuwana M, et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci. 2001;42:111-119. (Pubitemid 32059417)
10. Gustafsson A, Remberger M, Winiarski J, et al. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transpl. 2000;25:1059-1065. (Pubitemid 30303595)
11. Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006;17:344-348. (Pubitemid 44215042)
12. Claes K, Kestelyn P. Ocular manifestations of graft versus host disease following bone marrow transplantation. Bull Soc Belge Ophtalmol. 2000; 277:21-26.
13. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:4-13. (Pubitemid 13175772)
14. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, et al. Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology. 2009;116:1624-1629.
15. Fahnehjelm KT, Törnquist AL, Winiarski J. Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol. 2008;86:253-258. (Pubitemid 351785096)
16. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol. 1989;107:1343-1348. (Pubitemid 19229080)
17. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006;108:756-762. (Pubitemid 44061381)
18. Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006; 107:3074-3080.
19. Carella AM, Champlin R, Slavin S, et al. Mini-allografts: ongoing trials in humans. Bone Marrow Transpl. 2000;25:345-350. (Pubitemid 30114026)
20. Kiang E, Tesavibul N, Yee R, et al. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transpl. 1998;22:147-151. (Pubitemid 28375653)
21. Kim H, Csaky KG, Gilger BC, et al. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease. Invest Ophthalmol Vis Sci. 2005;46:655-662. (Pubitemid 40270349)
22. Malta JB, Soong HK, Shtein RM, et al. Treatment of ocular graft-versushost disease with topical cyclosporine 0.05%. Cornea. 2010;29:1392-1396.
23. Wang Y, Ogawa Y, Dogru M, et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graftversus-host disease. Bone Marrow Transpl. 2008;41:293-302. (Pubitemid 351260385)
24. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood. 1992;80:2964-2968. (Pubitemid 23004498)
25. De Wit D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol. 1993;150:361-366. (Pubitemid 23133610)
26. Kim SK. Ocular graft vs. host disease. Ocul Surf. 2005;3:177-179.
27. Perry HD, Solomon R, Donnenfeld ED, et al. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol. 2008;126:1046-1050.
28. Westeneng AC, Hettinga Y, Lokhorst H, et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 2010;29:758-763.
29. Sáles CS, Johnston LJ, Ta CN. Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination. Cornea. 2011;30:143-149.
30. Ban Y, Ogawa Y, Goto E, et al. Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease. Eye. 2009;23:202-208.
31. Kosrirukvongs P, Chirapapaisan N, Visuthisakchai S, et al. Sjögren-like syndrome after bone marrow transplantation. J Med Assoc Thai. 2008;91: 1739-1747.
32. Chiang CC, Lin JM, Chen WL, et al. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea. 2007;26:861-863.
33. Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol. 2008;71:47-54.
34. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23: 762-770. (Pubitemid 39447304)